Phase I trial of vinflunine and pemetrexed in refractory solid tumors

By Sanoff Hanna   Davies Janine   Walko Christine   Buie Larry   Chiu Wing-Keung   Ivanova Anastasia   O’Neil Bert   Stinchcombe Thomas   Keller Kimberly   Dees E.  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 131-136

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 trial of Anvirzel™ in patients with refractory solid tumors

By Mekhail Tarek   Kaur Hanspreet   Ganapathi Ram   Budd G.   Elson Paul   Bukowski Ronald  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 423-427

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors

By Kalmadi S.   Davis M.   Dowlati A.   O’Keefe S.   Cline-Burkhardt M.   Pelley R.   Borden E.   Dreicer R.   Bukowski R.   Mekhail T.  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 211-216

Springer Publishing Company

Access to resources Recommend Favorite

Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors

By Hubbard Joleen   Erlichman Charles   Toft David   Qin Rui   Stensgard Bridget   Felten Sara   Ten Eyck Cynthia   Batzel Gretchen   Ivy S.   Haluska Paul  

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 473-480

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I Clinical and Pharmacokinetic Study of Fenretinide Combined with Paclitaxel and Cisplatin for Refractory Solid Tumors

By Otterson G.   Lavelle J.   Villalona-Calero M.   Shah M.   Wei X.   Chan K.   Fischer B.   Grever M.  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 555-562

Springer Publishing Company

Access to resources Recommend Favorite